Jefferies Financial Group Inc. Moderna, Inc. Call Options Transaction History

Jefferies Financial Group Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $1.23 Million - $2.42 Million	-19,300 Reduced 94.15%	1,200 $80,000
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $1.84 Million - $3.03 Million	-18,200 Reduced 47.03%	20,500 $2.43 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $3.3 Million - $4.47 Million	38,700 New	38,700 $4.12 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.